(Q35081097)

English

Cancer gene therapy

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Cancer gene therapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

0 references

cancer gene therapy

1 reference

based on heuristic

inferred from title

author name string

Joanne T Douglas

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Technology in Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

51-64

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

A paradigm for cancer treatment using the retinoblastoma gene in a mouse model

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studies

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin.

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

P53 gene replacement for cancer--interactions with DNA damaging agents

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Gene targeting via triple-helix formation

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Antisense anticancer oligonucleotide therapeutics

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agents

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma.

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Simple RNA enzymes with new and highly specific endoribonuclease activities

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Functional inactivation of genes by dominant negative mutations

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Inhibition of PDGF β Receptor Signal Transduction by Coexpression of a Truncated Receptor

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Dominant negative mutants of transforming growth factor-beta 1 inhibit the secretion of different transforming growth factor-beta isoforms

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Studies on the use of viruses in the treatment of carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Reovirus therapy of tumors with activated Ras pathway

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Reovirus as an oncolytic agent against experimental human malignant gliomas

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Reovirus therapy of lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Reovirus oncolysis of human breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Systemic therapy of myeloma xenografts by an attenuated measles virus

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Oncolytic herpes simplex virus vectors for cancer virotherapy

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Replicative adenoviruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor.

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model.

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Targeted adenoviral vectors

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factor

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954.

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Secreted human beta-glucuronidase: a novel tool for gene-directed enzyme prodrug therapy

1 reference

https://api.crossref.org/works/10.1177%2F153303460300200107

21 January 2018

Identifiers

10.1177/153303460300200107

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35081097&oldid=2061185766"